|
|
Bone marrow (100895)
Sponsor: COG (ANHL 0221)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase II Study of the Combination of Cyclophosphamide, Prednisone, and Rituximab (CPR) in Children, Adolescents and Young Adults with CD20 Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplant (SOT)
None Available
|
 |
|
|
More...
|
|
|
|
|
Brain (100901)
Sponsor: COG (ACNS0423)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase II Study of Concurrent Radiation and Temozolomide Followed by Temozolomide and CCNU in the Treatment of Children with High Grade Glioma
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
Brain (101113)
Sponsor: COG (ACNS 0332)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
None Available
|
|
|
|
|
More...
|
|
|
|
Brain (101157)
Sponsor: COG (ANBL0032)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch 14.18) in High Risk Neuroblastome following Myeloablatice Therapy and Autogolous Stem Cell Rescue
None Available
|
|
|
|
|
More...
|
|
|
|
|
Eye (100970)
Sponsor: COG (ARET0332)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
|
|
|
|
|
Leukemia (101068)
Sponsor: COG (AAML 0531)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase II Randomized Trial of Gemtuzumag Ozogamicin (Mylotarg) Conbimed with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescent, and Young Adults.
None Available
|
|
|
|
|
More...
|
|
|
|
Leukemia (101093)
Sponsor: COG (AALL 0434)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia
None Available
|
|
|
|
|
More...
|
|
|
|
|
Leukemia (101111)
Sponsor: COG (AALL 0433)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Intensive treatment for intermediate-risk relapse of childhood B-Precursor acute lymphoblastic leukemia (all): A randomized trial of vincristine strategies
None Available
|
|
|
|
|
More...
|
|
|
|
Lymphoma (100951)
Sponsor: COG (AHOD0031)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase III Group-Wide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin's Disease
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
Lymphoma (101156)
Sponsor: COG (ANHL0131)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase III, Trial of Treatment of Advanced-Staged Anaplastic Large Cell Lymphoma (ALCL) with Standard APO (Doxorubicin, Preednisone, Vincristine) versus Consolidation with Regimen including Vinblastine.
None Available
|
|
|
|
|
More...
|
|
|
|
Multiple Sites (100849)
Sponsor: COG (AWOD 0031)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin's Disease
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
|
|
|
|
|
Neuroblastoma (100924)
Sponsor: COG (A3973)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
|
Rhabdomyosarcoma (100879)
Sponsor: COG (ARST0331)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide with or without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
None Available
|
|
|
|
|
More...
|
|
|
|
Sarcoma (100961)
Sponsor: COG (AOST 0331)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy
None Available
|
|
|
|
|
More...
|
|
|
|
Sarcoma (101042)
Sponsor: COG (ARST 0431)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients with High-Risk Rhabdomyosarcoma.
None Available
|
|
|
|
|
More...
|
|
|
|
|
Solid Tumor (100972)
Sponsor: COG (ACCL04C2)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors (02-AT-0172)
None Available
|
|
|
|
|
More...
|
|
|
|
Solid Tumor (101080)
Sponsor: COG (ARST0531)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS)
None Available
|
|
|
|
|
More...
|
|
|
|
testes (100960)
Sponsor: COG (AGCT 0IPI)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalatin Dose Cyclophosphamide Therapy for Children with High-Risk Malignant Germ Cell Tumors
None Available
|
|
|
|
|
More...
|
|
|
|
Testis (100896)
Sponsor: COG (ACNS 0122)
|
By Pediatric on
7/5/2008 10:00 AM
|
|
|
A Phase II Study to Assess the Ability of Neoadjuvant Chemotherapy +/- Second Look Surgery to Eliminate All Measurable Disease Prior to Radiotherapy for Non-Germinomatous Germ Cell Tumor (NGGCT)
None Available
|
|
|
|
|
More...
|
|